HomeBIOTECHNOLOGY

BIOTECHNOLOGY

SARS-CoV-2 Plus ELITe MGB Assay EAU Submitted

The SARS-CoV-2 Plus ELITe MGB Assay is developed and manufactured in Bothell, Wash., and it uses RNase P as an endogenous control for increased test reliability.

Cala Health New Data Reported at ISPOR Euro 2020

The new data demonstrates the increasing prevalence of essential tremor (ET) from 2010 to 2018; a high rate of depression and anxiety in patients with ET; and the safety and efficacy of Cala Trio when used in a real-world setting to treat ET.

SOFIE Signs Commercial Supply Agreemet with Lantheus Holdings

SOFIE notes following U.S. Food and Drug Administration ("FDA") approval, Lantheus will have a critical need for dependable and scalable manufacturing and distribution partners to support PyL™.

SARS-CoV-2 Real-time RT-PCR Assay Receives CE Mark for Saliva and Sample Pooling to Test Symptomatic and Asymptomatic Individuals

November 11, 2020 SARS-CoV-2 Real-time RT-PCR Assay received CE-IVD marking for the use of saliva as specimen type and the option to pool up to five...

Precision Genetics Launches a New Diagnostic to Detect COVID-19 and the Flu

The test is available to health systems, providers, employers, and academic institutions alike. 

DnaNUDGE COVID “Bubble Test” First in the United Kingdom Launches

The breakthrough rapid DnaNudge RT-PCR test is now open for online booking and is available by appointment only from DnaNudge’s flagship store in London’s Covent Garden, and will be available as an at-home, by-post service throughout the UK within weeks.

Novel Biomedical Analysis Platform to Drive Innovation in Clinical Diagnostics and Drug Discovery Research Launches

The new Microflow-nanospray Electrospray Ionization (MnESI) Source offers unmatched sensitivity, robustness and reproducibility for small-volume, high-throughput analysis of antibodies, proteins, nucleic acids and lipids derived from cells and human plasma.

Cerapedics: i-FACTOR+ MATRIX Launches in Canada

i-FACTOR+ MATRIX utilizes a small proprietary peptide (P-15) technology developed by Cerapedics to support bone growth through cell attraction, attachment, and activation.

ENPICOM Services Neogene Therapeutics with its T Cell Repertoire Sequencing Data Handling and Analysis Solution

ENPICOM has additionally developed a number of customizations making sure that the platform’s functionality fits Neogene’s specific data handling workflow to help Neogene’s research team leverage the full potential of their immune repertoire data.